> Products > 916420-27-4

China 916420-27-4 Factory

Assume full accountability to meet all requires of our purchasers; realize continual advancements by selling the advancement of our customers; grow to be the final permanent cooperative partner of consumers and maximize the interests of clientele for 916420-27-4,CAS NO 916420-27-4,MRTX-849 intermediate,MRTX-849 advance intermediate,tert-Butyl 2,4-dichloro-5,6,7,8-tetrahydropyrido, Never-ending improvement and striving for 0% deficiency are our two main quality policies. Should you need anything, don't hesitate to contact us.
916420-27-4, We care about every steps of our services, from factory selection, product development & design, price negotiation, inspection, shipping to aftermarket. Now we have implemented a strict and complete quality control system, which ensures that each product can meet quality requirements of customers. Besides, all of our solutions have been strictly inspected before shipment. Your Success, Our Glory: Our aim is to help customers realize their goals. We're making great efforts to achieve this win-win situation and sincerely welcome you to join us.

Hot Products

1-Butanaminium, N,N,N-tributyl-, (1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl sulfate
Product Name:1-Butanaminium, N,N,N-tributyl-, (1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl sulfate
Molecular Formula:C23H46N4O6S
Molecular Weight:506.7
CAS Registry Number:1192651-80-1
4-(2-CYANOPROPAN-2-YLAMINO)-2-FLUORO-N-METHYLBENZAMIDE
Product Name:4-(2-CYANOPROPAN-2-YLAMINO)-2-FLUORO-N-METHYLBENZAMIDE
Molecular Formula:C12H14FN3O
Molecular Weight:235.26
CAS Registry Number:915087-32-0
4-Fluorobenzonitrile
Product Name:4-Fluorobenzonitrile
Molecular Formula:C7H4FN
Molecular Weight:121.11
CAS Registry Number:1194-02-1
4-(Hydroxymethyl)phenylboronic acid
Product Name:4-(Hydroxymethyl)phenylboronic acid
Molecular Formula:C7H9BO3
Molecular Weight:151.96
CAS Registry Number:59016-93-2
1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-[[2-(triMethylsilyl)ethoxy]Methyl]-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-, (βR)-
Product Name:1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-[[2-(triMethylsilyl)ethoxy]Methyl]-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-, (βR)-
Molecular Formula:C23H32N6OSi
Molecular Weight:436.63
CAS Registry Number:941685-40-1
4-Nitrobenzyl hydrogen malonate
Product Name:4-Nitrobenzyl hydrogen malonate
Molecular Formula:C10H9NO6
Molecular Weight:239.18
CAS Registry Number:77359-11-6

Related Blog
Reviews

What is the difference between API and FDF in pharma？
In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”
Prostate Cancer and Darolutamide
Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).
Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS
Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...
FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC
On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?
API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.
CAS No. 144689-24-7 Olmesartan Introduction
Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

Related Search

CAS NO 916420-27-4

China 916420-27-4 Factory

Related Products

Hot Products

1-Butanaminium, N,N,N-tributyl-, (1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl sulfate

4-(2-CYANOPROPAN-2-YLAMINO)-2-FLUORO-N-METHYLBENZAMIDE

4-Fluorobenzonitrile

4-(Hydroxymethyl)phenylboronic acid

1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-[[2-(triMethylsilyl)ethoxy]Methyl]-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-, (βR)-

4-Nitrobenzyl hydrogen malonate

What is the difference between API and FDF in pharma？

Prostate Cancer and Darolutamide

Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

CAS No. 144689-24-7 Olmesartan Introduction

Frances 2022-12-03 15:44:18

Annabelle 2023-08-03 05:30:59

Eudora 2023-10-14 13:12:34

Nicci Hackner 2023-01-07 20:41:03

Agatha 2024-01-08 02:45:34

Ryan 2022-05-04 21:28:47

Related Search

Send Inquiry